He Ophthalmology Co., Ltd.
何氏眼科
301103
Shenzhen Stock Exchange
Key Financials
Announcements
Announcement on the Implementation of 2025 Annual Equity Distribution
Independent Director Candidate Statement and Commitment (Feng Jun)
Independent Director Nominee Statement and Commitment (Feng Jun)
Independent Director Candidate Statement and Commitment (Sun Li)
Independent Director Nominee Statement and Commitment (Sun Li)
Announcement on the Expiration of Independent Director's Term and the Re-election of Independent Directors, and Adjustment of Special Committee Members of the Board
Legal Opinion from Beijing Zhonglun Law Firm on the 2025 Annual Shareholders' Meeting of Liaoning He’s Eye Hospital Group Co., Ltd.
Announcement of Resolutions from the 2025 Annual Shareholders' Meeting
Notice of the 2026 Second Extraordinary Shareholders' Meeting
Announcement of Resolutions from the 19th Meeting of the 3rd Board of Directors
Announcement on the completion of the share reduction plan by shareholders holding more than 5%
Zhongyuan Securities Co., Ltd. on the Summary Report of the First Public Offering of Shares and Listing on the Growth Enterprise Market of Liaoning He’s Ophthalmology Hospital Group Co., Ltd.
2025 Annual Audit Report
Zhongyuan Securities Co., Ltd. Special Review Opinion on the Storage and Use of Raised Funds in 2025 for Liaoning He’s Ophthalmology Hospital Group Co., Ltd.
Announcement on the Renewal of the Accounting Firm
Zhongyuan Securities Co., Ltd. 2025 Annual Continuous Supervision Tracking Report on Liaoning He’s Ophthalmology Hospital Group Co., Ltd.
2025 Annual Board of Directors Work Report
Announcement on the Confirmation of 2025 Annual Compensation for Directors and Senior Management and the 2026 Annual Compensation Plan
2025 Annual Independent Director Work Report (Li Hui)
2025 Annual Independent Director Work Report (Zhu Jie)
2025 Annual Independent Director Work Report (Wang Houshuang)
Announcement on Holding the 2025 Annual Online Performance Briefing
2025 Environmental, Social, and Governance (ESG) Report
Zhongyuan Securities Co., Ltd. Review Opinion on Liaoning He’s Ophthalmology Hospital Group Co., Ltd. 2025 Annual Internal Control Self-Assessment Report
Internal Control Audit Report
2025 Annual Internal Control Self-Assessment Report
Announcement on the Provision for Asset Impairment in 2025
Special Report on the Storage, Management, and Use of Raised Funds in 2025
Notice of the 2025 Annual Shareholders' Meeting
Third Board of Directors Eighteenth Meeting Resolution Announcement
Announcement on the 2025 Annual Profit Distribution Plan
2026 First Quarter Report
Verification Report on the Annual Storage and Use of Raised Funds
2025 Annual Audit Accountant Performance Evaluation Report
Board of Directors Audit Committee Report on the Evaluation of the Accounting Firm's Performance in 2025 and the Fulfillment of Supervision Responsibilities
Special Explanation on Non-operating Fund Occupation and Other Related Fund Transactions
2025 Annual Non-operating Fund Occupation and Other Related Fund Transactions Summary Table
Board of Directors Special Opinion on the Independence Assessment of Independent Directors
2025 Annual Report
2025 Annual Report Summary
Announcement on the Expiration of Independent Directors' Terms
Announcement on the completion of private equity fund filing for jointly investing in an industrial fund with professional investment institutions
Announcement on the Estimated Daily Related Party Transactions for 2026
Resolution Announcement of the Seventeenth Meeting of the Third Board of Directors
Announcement on the Chairman Acting as Board Secretary
Notes & Comments
Sign in to leave a comment or private note.
Loading…